<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-25499" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Myxopapillary Ependymoma</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Limaiem</surname>
            <given-names>Faten</given-names>
          </name>
          <aff>University of Tunis El Manar, Tunis Faculty of Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Das</surname>
            <given-names>Joe M.</given-names>
          </name>
          <aff>Imperial College Healthcare NHS Trust, London</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Faten Limaiem declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Joe Das declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>1</day>
          <month>1</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-25499.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Myxopapillary ependymoma is a distinct subtype of spinal cord ependymomas with a predilection for the lumbosacral region. To achieve satisfactory outcomes, the basic and clinical aspects of myxopapillary ependymomas must be clearly defined. This activity focuses on the etiology, evaluation, management, and complications of myxopapillary ependymomas and highlights the role of the interprofessional team in improving healthcare outcomes.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of myxopapillary ependymoma.</p></list-item><list-item><p>Assess&#x000a0;the appropriate evaluation of myxopapillary ependymoma.</p></list-item><list-item><p>Evaluate&#x000a0;the management options available for myxopapillary ependymoma.</p></list-item><list-item><p>Communicate&#x000a0;interprofessional team strategies for improving care coordination to advance the care of myxopapillary ependymoma and improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25499&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25499">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-25499.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Initially described by&#x000a0;Kernohan in 1932, myxopapillary ependymoma&#x000a0;is a distinct subtype of spinal cord ependymomas with a predilection for the lumbosacral region.<xref ref-type="bibr" rid="article-25499.r1">[1]</xref>&#x000a0;It&#x000a0;represents 13% of all spinal ependymomas and&#x000a0;accounts for 90% of all tumors in the conus medullaris.<xref ref-type="bibr" rid="article-25499.r2">[2]</xref><xref ref-type="bibr" rid="article-25499.r3">[3]</xref>&#x000a0;Myxopapillary ependymoma is a benign and slow-growing neoplasm that has been histologically classified as grade 2, according to&#x000a0;the World Health Organization (WHO) classification.</p>
      </sec>
      <sec id="article-25499.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Myxopapillary ependymoma arises from the ependymal glia of the filum terminale. No risk factors for the development of this tumor have been described. Extradural myxopapillary ependymomas are thought to arise from&#x000a0;the coccygeal medullary vestige or the&#x000a0;extradural remnants of the filum terminale.<xref ref-type="bibr" rid="article-25499.r4">[4]</xref></p>
      </sec>
      <sec id="article-25499.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Myxopapillary ependymomas&#x000a0;account for&#x000a0;1% to 5% of all spinal neoplasms and&#x000a0;approximately 13%. In the American population, their incidence was 1.00 per million person-years. The age at&#x000a0;onset varies between 30 and 50 years&#x000a0;(mean age, 35&#x000a0;years).&#x000a0;The most common location of myxopapillary ependymoma is the lumbosacral spine segment, mainly in the conus medullaris and cauda equina regions. Other rare locations include the cerebral ventricles and the brain.<xref ref-type="bibr" rid="article-25499.r5">[5]</xref></p>
      </sec>
      <sec id="article-25499.s5" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>
<bold>Macroscopy</bold>
</p>
        <p>Grossly,&#x000a0;myxopapillary ependymomas are sausage-shaped and often encapsulated. They are reddish to purplish in color and soft in consistency.<xref ref-type="bibr" rid="article-25499.r6">[6]</xref>&#x000a0;Mucinous degeneration or hemorrhage may sometimes be seen in these tumors.<xref ref-type="bibr" rid="article-25499.r7">[7]</xref></p>
        <p>
<bold>Microscopy</bold>
</p>
        <p>Histologically, myxopapillary ependymomas are characterized by a papillary architecture. In the center of the papillae, there are blood vessels that are surrounded by&#x000a0;cuboidal to spindled glial cells. The stroma is myxoid and alcian blue&#x02013;positive.<xref ref-type="bibr" rid="article-25499.r8">[8]</xref>&#x000a0;Vascular hyalinization&#x000a0;and other degenerative changes are often prominent. Some tumors may&#x000a0;show&#x000a0;a more compact fascicular pattern with occasional perivascular pseudorosettes with mucin-rich microcysts and occasional perivascular pseudorosettes. Sometimes, the tumor may exhibit&#x000a0;rounded to spiculated collagen &#x0201c;balloons.&#x0201d; In these tumors, mitotic figures are usually scarce. Endothelial proliferation and necrosis are absent. Some authors described anaplastic and giant cell variants of myxopapillary ependymomas in isolated case reports.<xref ref-type="bibr" rid="article-25499.r9">[9]</xref></p>
        <p>
<bold>Immunohistochemistry</bold>
</p>
        <p>An immunohistochemical study is frequently required to distinguish myxopapillary ependymoma from chondrosarcoma or chordoma. The tumor cells are often positive for S-100, GFAP, CD99, and COX-2. However, they are negative for&#x000a0;endomysial antibodies.<xref ref-type="bibr" rid="article-25499.r8">[8]</xref></p>
      </sec>
      <sec id="article-25499.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The clinical presentation of myxopapillary ependymomas is not specific and is similar to that of other intradural tumors located below the spinal cord in the region of the filum terminale.<xref ref-type="bibr" rid="article-25499.r1">[1]</xref>&#x000a0;The symptoms related to this tumor are influenced by the size, the presentation site, and the tumor's local extent. An indolent and slow clinical course characterizes myxopapillary ependymomas. Most patients&#x000a0;experience symptoms for months to years&#x000a0;before diagnosis and have a nonspecific presentation.<xref ref-type="bibr" rid="article-25499.r10">[10]</xref></p>
        <p>
<bold>Nonspecific Symptoms&#x000a0;</bold>
</p>
        <p>Patients with myxopapillary ependymomas usually complain of radicular and back pain&#x000a0;worsening during the night and in the&#x000a0;lounging position.<xref ref-type="bibr" rid="article-25499.r1">[1]</xref></p>
        <p>
<bold>Other Symptoms of Myxopapillary Ependymoma</bold>
</p>
        <p>Patients with myxopapillary ependymoma may complain of motor, sensory, urinary, and gait abnormalities.<xref ref-type="bibr" rid="article-25499.r1">[1]</xref>&#x000a0;Among the other symptoms of myxopapillary ependymoma, enlargement of the neural foramina scoliosis, and scalloping of the vertebral body can be distinguished. Sudden exacerbation of the symptoms with leg weakness and sphincter disturbances can occur secondary to hemorrhage.<xref ref-type="bibr" rid="article-25499.r1">[1]</xref></p>
      </sec>
      <sec id="article-25499.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Magnetic resonance imaging is the best modality for diagnosing myxopapillary ependymoma because of its superior soft-tissue contrast. Other imaging studies include plain radiographs and computed tomography scans. Plain radiographs and&#x000a0;computed tomography scans can reveal scalloping of the vertebral bodies secondary to the spinal canal expansion caused by a large myxopapillary ependymoma. Magnetic resonance imaging helps identify the extent of the tumor and its relationship to intraspinal structures. It also allows for visualization of the cauda equina both above and below the tumor and identifies drop metastases in the subarachnoid space. Such information is useful in preoperative surgical planning. Magnetic resonance imaging findings in myxopapillary ependymomas are nonspecific.<xref ref-type="bibr" rid="article-25499.r4">[4]</xref><xref ref-type="bibr" rid="article-25499.r11">[11]</xref>&#x000a0;On magnetic resonance imaging, the lesion is iso- to hypointense on T1 and hyperintense on T2. Owing to their mucin content, the signal is hyperintense in myxopapillary ependymoma. Moreover, the tumor is&#x000a0;heterogeneous after gadolinium injection. Hemorrhage and cyst formations are common features that contribute to signal inhomogeneity.<xref ref-type="bibr" rid="article-25499.r11">[11]</xref>&#x000a0;However, these tumors do contain certain features that help suggest the diagnosis. These features include:</p>
        <list list-type="order">
          <list-item>
            <p>An intradural extramedullary thoracolumbar mass</p>
          </list-item>
          <list-item>
            <p>The tumor extends to several vertebral levels in the lumbar and sacral canal.</p>
          </list-item>
          <list-item>
            <p>It is hypointense to isointense on T1-weighted images.</p>
          </list-item>
          <list-item>
            <p>It is hyperintense on T2-weighted images.</p>
          </list-item>
          <list-item>
            <p>There is an intense, homogeneous enhancement after the administration of contrast.</p>
          </list-item>
          <list-item>
            <p>There is usually a slightly lower intensity region at tumor margin on T2-weighted sequences.</p>
          </list-item>
          <list-item>
            <p>Cystic rostral or caudal degeneration exists in 50% of cases.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25499.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>There are no definitive treatment guidelines due to the rarity of myxopapillary ependymomas. The consensus is that surgical&#x000a0;excision is the preferred initial treatment modality.<xref ref-type="bibr" rid="article-25499.r12">[12]</xref>&#x000a0;Early detection and treatment of patients affected by myxopapillary ependymomas&#x000a0;are crucial to achieving optimal patient outcomes. The best treatment modality for myxopapillary ependymoma is complete surgical resection, associated with a complete resolution for most patients.<xref ref-type="bibr" rid="article-25499.r13">[13]</xref><xref ref-type="bibr" rid="article-25499.r14">[14]</xref>&#x000a0;Surgery should be performed early&#x000a0;to guarantee&#x000a0;better postoperative outcomes.<xref ref-type="bibr" rid="article-25499.r15">[15]</xref>&#x000a0;Complete resection of this tumor may be hazardous,&#x000a0;principally if the&#x000a0;tumor&#x000a0;involves the conus medullaris or is interlaced with the nerve roots of the cauda equina. Surgeons must be very careful&#x000a0;since nerve roots may also penetrate directly through the tumor.<xref ref-type="bibr" rid="article-25499.r16">[16]</xref>&#x000a0;In the case of subtotal resection, adjuvant radiotherapy is recommended. However, chemotherapy is used&#x000a0;in young children who are more prone to negative side effects from radiation therapy.<xref ref-type="bibr" rid="article-25499.r15">[15]</xref>&#x000a0;The efficacy of chemotherapy has not been established in myxopapillary ependymomas, although it has been suggested as a potential treatment to prevent a recurrence.<xref ref-type="bibr" rid="article-25499.r17">[17]</xref>&#x000a0;Radical surgery for myxopapillary ependymoma is associated with a favorable outcome in children and adults, as with other spinal cord ependymomas.<xref ref-type="bibr" rid="article-25499.r18">[18]</xref>&#x000a0;Long-term survival is&#x000a0;better in the case of&#x000a0;gross total removal of myxopapillary ependymoma rather than subtotal resection.<xref ref-type="bibr" rid="article-25499.r1">[1]</xref><xref ref-type="bibr" rid="article-25499.r16">[16]</xref></p>
      </sec>
      <sec id="article-25499.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnoses of filum terminale and small&#x000a0;conus&#x000a0;myxopapillary ependymomas include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Fibrous meningioma:<bold>&#x000a0;</bold>The&#x000a0;fibrillary variant of myxopapillary ependymomas may be confused with fibrous meningioma</p>
          </list-item>
          <list-item>
            <p>Paraganglioma: However,&#x000a0;myxopapillary ependymomas are chromogranin-A negative and GFAP positive</p>
          </list-item>
          <list-item>
            <p>Schwannoma: The fibrillary variant of myxopapillary ependymomas may be confused with schwannoma</p>
          </list-item>
        </list>
        <p>The epithelial and papillary variants of myxopapillary meningioma may mimic carcinoma or meningioma.</p>
        <p>The differential diagnosis of a large myxopapillary ependymoma that is responsible for sacral destruction includes:</p>
        <list list-type="bullet">
          <list-item>
            <p>Aneurysmal bone cyst</p>
          </list-item>
          <list-item>
            <p>Chondrosarcoma</p>
          </list-item>
          <list-item>
            <p>Chordoma</p>
          </list-item>
          <list-item>
            <p>Giant cell tumor</p>
          </list-item>
          <list-item>
            <p>Metastatic carcinoma:<bold>&#x000a0;</bold>However,&#x000a0;myxopapillary ependymomas are devoid of cytological atypia, have a lower Ki-67 LI, and are focally fibrillar</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25499.s10" sec-type="Radiation Oncology">
        <title>Radiation Oncology</title>
        <p>The therapeutic benefits of radiotherapy for myxopapillary ependymomas are still debated owing to the benign and slow-growing nature of the tumor. In 1 study, the authors reported no difference in irradiated versus nonirradiated patients after total or subtotal resection.<xref ref-type="bibr" rid="article-25499.r16">[16]</xref>&#x000a0;According to&#x000a0;other recent studies, postoperative radiotherapy is beneficial for patients who had subtotal resection of myxopapillary ependymoma and was considered the best treatment option for these patients because of the high risk of long-term recurrence in the case of subtotal resection of the tumor.<xref ref-type="bibr" rid="article-25499.r19">[19]</xref><xref ref-type="bibr" rid="article-25499.r20">[20]</xref><xref ref-type="bibr" rid="article-25499.r21">[21]</xref>&#x000a0;Other studies demonstrated that radiotherapy is significantly more beneficial in the case of subtotal resected myxopapillary ependymomas smaller than 6 cm compared to larger tumors (58% versus 92% 5- and 10-year progression-free survival).<xref ref-type="bibr" rid="article-25499.r22">[22]</xref></p>
      </sec>
      <sec id="article-25499.s11" sec-type="Staging">
        <title>Staging</title>
        <p>
<bold>World Health Organization classification:</bold>
</p>
        <p>Recently, the classification of central nervous system tumors has been moving toward a more molecularly oriented classification scheme. In the 2021 WHO classification of&#x000a0;central nervous system tumors, ependymal tumors are classified as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>Myxopapillary ependymoma&#x000a0;(grade 2)</p>
          </list-item>
          <list-item>
            <p>Subependymoma (grade 1)</p>
          </list-item>
          <list-item>
            <p>Classic ependymoma (grade 2)</p>
          </list-item>
          <list-item>
            <p>RELA fusion-protein positive ependymoma (grade 2 or 3; this is the only&#x000a0;molecularly classified ependymoma)</p>
          </list-item>
          <list-item>
            <p>Anaplastic ependymoma (grade 3)<xref ref-type="bibr" rid="article-25499.r23">[23]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25499.s12" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Currently, neither the histopathology nor the MIB-1 index appears to predict the natural history, likelihood of recurrence, or metastases. Patients should be followed postoperatively with serial&#x000a0;magnetic resonance imaging to monitor for tumor recurrence, even if a gross total resection was accomplished, because even then, recurrence rates of 10% to 19% have been reported.<xref ref-type="bibr" rid="article-25499.r1">[1]</xref><xref ref-type="bibr" rid="article-25499.r16">[16]</xref>&#x000a0;Despite the good results with surgery, tumor recurrence and dissemination may occur. Local recurrence and metastases have been related to the clinical history of less than 1 year, the extent of resection, atypical histology, and lesions extending into the substance of the spinal cord.<xref ref-type="bibr" rid="article-25499.r21">[21]</xref><xref ref-type="bibr" rid="article-25499.r24">[24]</xref>&#x000a0;Myxopapillary ependymomas are considered benign tumors of the central nervous system with long-term survival rates and a tendency for local recurrence. However, an aggressive course has occasionally been described, leading to cerebrospinal fluid dissemination and even systemic metastases.</p>
        <p>Despite its well-differentiated appearance, it occasionally shows aggressive behavior. Local progression is common, and systemic metastases have also been described, with the lungs being the organs most commonly affected. Systemic dissemination is more common in cases of a primary extraspinal location.<xref ref-type="bibr" rid="article-25499.r1">[1]</xref>&#x000a0;The estimated 10-year overall survival is 92.4%, with a 10-year&#x000a0;progression-free survival of 61.2%.<xref ref-type="bibr" rid="article-25499.r25">[25]</xref>&#x000a0;Age (&#x0003c;36 vs. &#x02265;36 years), treatment modality (surgery alone vs. surgery and radiotherapy), and extent of surgery are prognostic factors for local&#x000a0;control and progression-free survival. The 5-year overall survival rate of patients with myxopapillary ependymoma is excellent and varies from 90% to 100%.&#x000a0;Patients who undergo gross total resection of intradural myxopapillary ependymomas have a good prognosis, with a mean survival time of 19 years.<xref ref-type="bibr" rid="article-25499.r1">[1]</xref>&#x000a0;Although rarely encountered in children, myxopapillary ependymomas have a more aggressive clinical course with an increased risk of recurrence and dissemination when compared to the adult population. The reason for this more aggressive course in children is unclear.</p>
      </sec>
      <sec id="article-25499.s13" sec-type="Complications">
        <title>Complications</title>
        <p>Some authors&#x000a0;reported that en-bloc removal of encapsulated&#x000a0;myxopapillary ependymomas&#x000a0;of the filum terminale showed lower dissemination (10%) than myxopapillary ependymomas removed piecemeal (19%).<xref ref-type="bibr" rid="article-25499.r1">[1]</xref> During surgery, the rupture of the capsule of myxopapillary ependymoma may result in cerebrospinal fluid seeding and dissemination.<xref ref-type="bibr" rid="article-25499.r24">[24]</xref>&#x000a0;According to the literature, in 30% of the cases, dissemination and treatment failure may occur.<xref ref-type="bibr" rid="article-25499.r25">[25]</xref><xref ref-type="bibr" rid="article-25499.r24">[24]</xref>&#x000a0;The factors that increase the risk of recurrence and metastases are the extension of myxopapillary ependymoma into the substance of the spinal cord, a clinical history of less than&#x000a0;1 year, the extent of resection, and atypical tumor histology.<xref ref-type="bibr" rid="article-25499.r24">[24]</xref></p>
      </sec>
      <sec id="article-25499.s14" sec-type="Consultations">
        <title>Consultations</title>
        <p>Consultations that are typically requested for patients with this condition include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Neurosurgeon</p>
          </list-item>
          <list-item>
            <p>Neurologist</p>
          </list-item>
          <list-item>
            <p>Radiotherapist</p>
          </list-item>
          <list-item>
            <p>Radiologist</p>
          </list-item>
          <list-item>
            <p>Pathologist</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25499.s15" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients should consult with a neurologist when they suffer from radicular pain and back pain. The interprofessional team should ensure that the patients are well-informed about myxopapillary ependymoma. Patients&#x000a0;should be informed about educational websites to help them better understand this benign neoplasm, its prognosis, and&#x000a0;its treatment. Patient education is very important in deterring the processes that can cause a myxopapillary ependymoma. Specialty-trained nurses often&#x000a0;play a crucial role.</p>
      </sec>
      <sec id="article-25499.s16" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Although myxopapillary ependymomas are classified as benign tumors, dissemination and local recurrence pose a major challenge in their clinical treatment. Therefore, a close follow-up of the patients with myxopapillary ependymoma is mandatory to detect local recurrence or spread of the tumor.</p>
      </sec>
      <sec id="article-25499.s17" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The management of myxopapillary ependymoma requires an interprofessional approach involving a team that consists of a neurosurgeon, neurologist, radiotherapist, radiologist, and pathologist. The&#x000a0;primary clinicians&#x000a0;should refer patients with neurological deficits to a neurologist&#x000a0;or a neurosurgeon for further workup. All health professionals must coordinate their actions to enhance the management of patients with myxopapillary ependymoma. Coordination begins&#x000a0;with proper communication between clinicians, nurses, and pharmacists.&#x000a0;The optimal treatment of myxopapillary ependymoma relies on surgical removal of the tumor. The interprofessional team should perform an exhaustive preoperative workup to minimize postoperative complications.</p>
      </sec>
      <sec id="article-25499.s18">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25499&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25499">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/health/myxopapillary-ependymoma/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=25499">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/25499/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=25499">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-25499.s19">
        <title>References</title>
        <ref id="article-25499.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sonneland</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Scheithauer</surname>
                <given-names>BW</given-names>
              </name>
              <name>
                <surname>Onofrio</surname>
                <given-names>BM</given-names>
              </name>
            </person-group>
            <article-title>Myxopapillary ependymoma. A clinicopathologic and immunocytochemical study of 77 cases.</article-title>
            <source>Cancer</source>
            <year>1985</year>
            <month>Aug</month>
            <day>15</day>
            <volume>56</volume>
            <issue>4</issue>
            <fpage>883</fpage>
            <page-range>883-93</page-range>
            <pub-id pub-id-type="pmid">4016681</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25499.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Allen</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Siffert</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hukin</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Clinical manifestations of childhood ependymoma: a multitude of syndromes.</article-title>
            <source>Pediatr Neurosurg</source>
            <year>1998</year>
            <month>Jan</month>
            <volume>28</volume>
            <issue>1</issue>
            <fpage>49</fpage>
            <page-range>49-55</page-range>
            <pub-id pub-id-type="pmid">9693331</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25499.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Celli</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Cervoni</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cantore</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Ependymoma of the filum terminale: treatment and prognostic factors in a series of 28 cases.</article-title>
            <source>Acta Neurochir (Wien)</source>
            <year>1993</year>
            <volume>124</volume>
            <issue>2-4</issue>
            <fpage>99</fpage>
            <page-range>99-103</page-range>
            <pub-id pub-id-type="pmid">8304078</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25499.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Koeller</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Rosenblum</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Morrison</surname>
                <given-names>AL</given-names>
              </name>
            </person-group>
            <article-title>Neoplasms of the spinal cord and filum terminale: radiologic-pathologic correlation.</article-title>
            <source>Radiographics</source>
            <year>2000</year>
            <season>Nov-Dec</season>
            <volume>20</volume>
            <issue>6</issue>
            <fpage>1721</fpage>
            <page-range>1721-49</page-range>
            <pub-id pub-id-type="pmid">11112826</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25499.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Feldman</surname>
                <given-names>WB</given-names>
              </name>
              <name>
                <surname>Clark</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Safaee</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ames</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Parsa</surname>
                <given-names>AT</given-names>
              </name>
            </person-group>
            <article-title>Tumor control after surgery for spinal myxopapillary ependymomas: distinct outcomes in adults versus children: a systematic review.</article-title>
            <source>J Neurosurg Spine</source>
            <year>2013</year>
            <month>Oct</month>
            <volume>19</volume>
            <issue>4</issue>
            <fpage>471</fpage>
            <page-range>471-6</page-range>
            <pub-id pub-id-type="pmid">23971762</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25499.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chan</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Becker</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Hoffman</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Humphreys</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Hendrick</surname>
                <given-names>EB</given-names>
              </name>
              <name>
                <surname>Fitz</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Chuang</surname>
                <given-names>SH</given-names>
              </name>
            </person-group>
            <article-title>Myxopapillary ependymoma of the filum terminale and cauda equina in childhood: report of seven cases and review of the literature.</article-title>
            <source>Neurosurgery</source>
            <year>1984</year>
            <month>Feb</month>
            <volume>14</volume>
            <issue>2</issue>
            <fpage>204</fpage>
            <page-range>204-10</page-range>
            <pub-id pub-id-type="pmid">6709144</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25499.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Van Hoe</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Mebis</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Bali</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gielen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Dekeyzer</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Myxopapillary ependymoma of the sacrum.</article-title>
            <source>Acta Neurol Belg</source>
            <year>2020</year>
            <month>Feb</month>
            <volume>120</volume>
            <issue>1</issue>
            <fpage>227</fpage>
            <page-range>227-229</page-range>
            <pub-id pub-id-type="pmid">31555979</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25499.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Specht</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>TW</given-names>
              </name>
              <name>
                <surname>DeGirolami</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Price</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Myxopapillary ependymoma of the filum terminale. A light and electron microscopic study.</article-title>
            <source>Cancer</source>
            <year>1986</year>
            <month>Jul</month>
            <day>15</day>
            <volume>58</volume>
            <issue>2</issue>
            <fpage>310</fpage>
            <page-range>310-7</page-range>
            <pub-id pub-id-type="pmid">3521831</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25499.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Manasa</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Uppin</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Sundaram</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Analysis of squash smear cytology of ependymomas.</article-title>
            <source>Acta Cytol</source>
            <year>2012</year>
            <volume>56</volume>
            <issue>2</issue>
            <fpage>183</fpage>
            <page-range>183-8</page-range>
            <pub-id pub-id-type="pmid">22378082</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25499.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chinn</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Donaldson</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Dahl</surname>
                <given-names>GV</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Huhn</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Fisher</surname>
                <given-names>PG</given-names>
              </name>
            </person-group>
            <article-title>Management of children with metastatic spinal myxopapillary ependymoma using craniospinal irradiation.</article-title>
            <source>Med Pediatr Oncol</source>
            <year>2000</year>
            <month>Oct</month>
            <volume>35</volume>
            <issue>4</issue>
            <fpage>443</fpage>
            <page-range>443-5</page-range>
            <pub-id pub-id-type="pmid">11025481</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25499.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wippold</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Smirniotopoulos</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Moran</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Suojanen</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Vollmer</surname>
                <given-names>DG</given-names>
              </name>
            </person-group>
            <article-title>MR imaging of myxopapillary ependymoma: findings and value to determine extent of tumor and its relation to intraspinal structures.</article-title>
            <source>AJR Am J Roentgenol</source>
            <year>1995</year>
            <month>Nov</month>
            <volume>165</volume>
            <issue>5</issue>
            <fpage>1263</fpage>
            <page-range>1263-7</page-range>
            <pub-id pub-id-type="pmid">7572515</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25499.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bates</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Milano</surname>
                <given-names>MT</given-names>
              </name>
            </person-group>
            <article-title>Myxopapillary ependymoma: a SEER analysis of epidemiology and outcomes.</article-title>
            <source>J Neurooncol</source>
            <year>2016</year>
            <month>Sep</month>
            <volume>129</volume>
            <issue>2</issue>
            <fpage>251</fpage>
            <page-range>251-8</page-range>
            <pub-id pub-id-type="pmid">27306443</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25499.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Klekamp</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Spinal ependymomas. Part 1: Intramedullary ependymomas.</article-title>
            <source>Neurosurg Focus</source>
            <year>2015</year>
            <month>Aug</month>
            <volume>39</volume>
            <issue>2</issue>
            <fpage>E6</fpage>
            <pub-id pub-id-type="pmid">26235023</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25499.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tobin</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Geraghty</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Engelhard</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Linninger</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Mehta</surname>
                <given-names>AI</given-names>
              </name>
            </person-group>
            <article-title>Intramedullary spinal cord tumors: a review of current and future treatment strategies.</article-title>
            <source>Neurosurg Focus</source>
            <year>2015</year>
            <month>Aug</month>
            <volume>39</volume>
            <issue>2</issue>
            <fpage>E14</fpage>
            <pub-id pub-id-type="pmid">26235012</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25499.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ferrante</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mastronardi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Celli</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lunardi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Acqui</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fortuna</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Intramedullary spinal cord ependymomas--a study of 45 cases with long-term follow-up.</article-title>
            <source>Acta Neurochir (Wien)</source>
            <year>1992</year>
            <volume>119</volume>
            <issue>1-4</issue>
            <fpage>74</fpage>
            <page-range>74-9</page-range>
            <pub-id pub-id-type="pmid">1481757</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25499.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bagley</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kothbauer</surname>
                <given-names>KF</given-names>
              </name>
              <name>
                <surname>Bookland</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Epstein</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Jallo</surname>
                <given-names>GI</given-names>
              </name>
            </person-group>
            <article-title>Long term outcomes following surgical resection of myxopapillary ependymomas.</article-title>
            <source>Neurosurg Rev</source>
            <year>2009</year>
            <month>Jul</month>
            <volume>32</volume>
            <issue>3</issue>
            <fpage>321</fpage>
            <page-range>321-34; discussion 334</page-range>
            <pub-id pub-id-type="pmid">19221818</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25499.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fegerl</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Marosi</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Stabilization of metastatic myxopapillary ependymoma with sorafenib.</article-title>
            <source>Rare Tumors</source>
            <year>2012</year>
            <month>Jun</month>
            <day>26</day>
            <volume>4</volume>
            <issue>3</issue>
            <fpage>e42</fpage>
            <pub-id pub-id-type="pmid">23087798</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25499.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schweitzer</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Batzdorf</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>Ependymoma of the cauda equina region: diagnosis, treatment, and outcome in 15 patients.</article-title>
            <source>Neurosurgery</source>
            <year>1992</year>
            <month>Feb</month>
            <volume>30</volume>
            <issue>2</issue>
            <fpage>202</fpage>
            <page-range>202-7</page-range>
            <pub-id pub-id-type="pmid">1545888</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25499.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Akyurek</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>TK</given-names>
              </name>
              <name>
                <surname>Little</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Allen</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>McCutcheon</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Mahajan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Maor</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Woo</surname>
                <given-names>SY</given-names>
              </name>
            </person-group>
            <article-title>Spinal myxopapillary ependymoma outcomes in patients treated with surgery and radiotherapy at M.D. Anderson Cancer Center.</article-title>
            <source>J Neurooncol</source>
            <year>2006</year>
            <month>Nov</month>
            <volume>80</volume>
            <issue>2</issue>
            <fpage>177</fpage>
            <page-range>177-83</page-range>
            <pub-id pub-id-type="pmid">16648988</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25499.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gilhuis</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Kappelle</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Beute</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Wesseling</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Grotenhuis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Boerman</surname>
                <given-names>RH</given-names>
              </name>
            </person-group>
            <article-title>Radiotherapy for partially resected spinal ependymomas: a retrospective study of 60 cases.</article-title>
            <source>Oncol Rep</source>
            <year>2003</year>
            <season>Nov-Dec</season>
            <volume>10</volume>
            <issue>6</issue>
            <fpage>2079</fpage>
            <page-range>2079-82</page-range>
            <pub-id pub-id-type="pmid">14534747</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25499.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schild</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Nisi</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>In regard to the radiotherapy of myxopapillary ependymomas.</article-title>
            <source>Int J Radiat Oncol Biol Phys</source>
            <year>2002</year>
            <month>Jul</month>
            <day>01</day>
            <volume>53</volume>
            <issue>3</issue>
            <fpage>787</fpage>
            <pub-id pub-id-type="pmid">12062627</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25499.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wahab</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Simpson</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Michalski</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Mansur</surname>
                <given-names>DB</given-names>
              </name>
            </person-group>
            <article-title>Long term outcome with post-operative radiation therapy for spinal canal ependymoma.</article-title>
            <source>J Neurooncol</source>
            <year>2007</year>
            <month>May</month>
            <volume>83</volume>
            <issue>1</issue>
            <fpage>85</fpage>
            <page-range>85-9</page-range>
            <pub-id pub-id-type="pmid">17206474</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25499.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Huynh</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Drazin</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lekovic</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Myxopapillary ependymoma with anaplastic features: A case report with review of the literature.</article-title>
            <source>Surg Neurol Int</source>
            <year>2018</year>
            <volume>9</volume>
            <fpage>191</fpage>
            <pub-id pub-id-type="pmid">30294495</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25499.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rezai</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Woo</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zagzag</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Epstein</surname>
                <given-names>FJ</given-names>
              </name>
            </person-group>
            <article-title>Disseminated ependymomas of the central nervous system.</article-title>
            <source>J Neurosurg</source>
            <year>1996</year>
            <month>Oct</month>
            <volume>85</volume>
            <issue>4</issue>
            <fpage>618</fpage>
            <page-range>618-24</page-range>
            <pub-id pub-id-type="pmid">8814165</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25499.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weber</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Vill&#x000e0;</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zaucha</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Pica</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Poortmans</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Anacak</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ozygit</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Baumert</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Haller</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Preusser</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Long-term outcome of patients with spinal myxopapillary ependymoma: treatment results from the MD Anderson Cancer Center and institutions from the Rare Cancer Network.</article-title>
            <source>Neuro Oncol</source>
            <year>2015</year>
            <month>Apr</month>
            <volume>17</volume>
            <issue>4</issue>
            <fpage>588</fpage>
            <page-range>588-95</page-range>
            <pub-id pub-id-type="pmid">25301811</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
